This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
36. In Schedule 7 (qualified persons)(1), after paragraph 12A insert—
“12B. In the case of an MM medicinal product or a POC medicinal product, the obligations in paragraphs 12(1)(a) and 12A(1)(a) may be satisfied by securing that each product has been manufactured and checked in accordance with these Regulations and the requirements of the marketing authorisation relating to the product.”.
Paragraph 12A was inserted by S.I. 2019/775. There are other amendments but none is relevant.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
